doctor male discussion penile clamp

U.S. Guidelines Relax Opposition to Prostate Cancer Screening

An influential physician task force backed by the U.S. government is softening its opposition to routine prostate cancer screening.  In proposed guidelines released today, the U.S. Preventive Services Task Force advised men aged 55 to 69 to discuss the pros and cons of screening with their doctors rather than avoiding it altogether. The task force continued to recommend against a blood test for prostate specific antigen (PSA) in men 70 and older, concluding the potential harms of routine screening still outweigh the benefits for this age group. Since the last guidelines came out in 2012, new evidence has emerged suggesting that PSA tests may help lower the odds that tumors spread to other parts of the body or prove fatal for men aged 55 to 69, said task force chair Dr. Kirsten Bibbins-Domingo, a researcher at the University of California, San Francisco. New evidence also suggests it’s becoming more common for doctors to skip aggressive treatments like surgery or radiation for men with low-risk prostate tumors in favor of doing periodic tests to see if tumors grow, an approach known as active surveillance. Read more.

Source: Reuters, April 11, 2017

bladder retraining timed intervals

Hatch Medical to Broker Innovative Male Urinary Incontinence Device

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™. MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence.  Read more.

Source: Yahoo Finance! February 16, 2017

medical research

Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone

Cytori Therapeutics, Inc. (CYTX) today announced that over half of 45 patients in the ADRESU trial in Japan have been enrolled and treated. ADRESU is a late phase, investigator-initiated Japanese clinical trial to study the efficacy and safety of Cytori Cell TherapyTM in men with stress urinary incontinence after prostatic intervention for prostate cancer or benign prostatic hypertrophy. Read more.

Source: Yahoo! Finance, December 14, 2016

Penile Clamp for Male Urinary Incontinence

doctor male discussion penile clamp

Your healthcare professional should be consulted prior to using a penile clamp for male urinary incontinence.

The penile clamp is a device that may be used to manage some urine leakage in some men.  It may be used by men after prostate surgery who have some urine leakage. The clamp, which has a soft foam inside, is placed half way down the shaft and when in place and closed, it compresses the urethra so that urine cannot escape. This clamp is sometimes referred to as a Cunningham clamp.  Some newer clamp designs also include an absorbent product with the clamp for extra security.Continue reading

Catheters for Managing Urinary Incontinence

catther in place in a male

Diagram of an intermittent catheter in place in a male for Clean Intermittent Catheterization (CIC).

There are three types of catheter products that are used for managing urinary incontinence: indwelling (sometimes called a Foley) catheters, suprapubic catheters, and  intermittent catheters. The process of catheterization prevents a difficult-to-empty bladder from becoming overly full and backing up into the kidneys.  This prevents kidney damage because these catheters drain urine from the bladder.Continue reading